These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 16255547)

  • 21. Vitamin D levels and bone metabolism in Chinese adult patients with inflammatory bowel disease.
    Tan B; Li P; Lv H; Li Y; Wang O; Xing XP; Qian JM
    J Dig Dis; 2014 Mar; 15(3):116-23. PubMed ID: 24354597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Update of recommendations for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions. Working Group on Osteoporosis and Mineral Metabolism of the Spanish Society of Endocrinology].
    Reyes-García R; García-Martín A; Varsavsky M; Rozas-Moreno P; Cortés-Berdonces M; Luque-Fernández I; Gómez Sáez JM; Vidal Casariego A; Romero Muñoz M; Guadalix Iglesias S; Fernández García D; Jódar Gimeno E; Muñoz Torres M;
    Endocrinol Nutr; 2015 May; 62(5):e47-56. PubMed ID: 25797189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: bone disease in inflammatory bowel disease.
    Schulte CM
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():43-9. PubMed ID: 15352893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The risk factor for low bone mineral density in patients with inflammatory bowel disease].
    Liu JB; Gao X; Zhang FB; Yang L; Xiao YL; Zhang RD; Li ZP; Hu PJ; Chen MH
    Zhonghua Nei Ke Za Zhi; 2009 Oct; 48(10):833-6. PubMed ID: 20079225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The frequency of osteoporosis screening in men with inflammatory bowel disease.
    Nguyen HD; Bakshi AK; Borum ML
    Am J Mens Health; 2010 Mar; 4(1):71-4. PubMed ID: 19477762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy insight: Osteoporosis in inflammatory bowel disease--advances and retreats.
    Bernstein CN; Leslie WD
    Nat Clin Pract Gastroenterol Hepatol; 2005 May; 2(5):232-9. PubMed ID: 16265206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pharmacological treatment of other types of secondary osteoporosis].
    Okazaki R
    Nihon Rinsho; 2015 Oct; 73(10):1740-5. PubMed ID: 26529940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiology of osteoporosis.
    Anil G; Guglielmi G; Peh WC
    Radiol Clin North Am; 2010 May; 48(3):497-518. PubMed ID: 20609888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment, prevention and treatment of osteoporosis in inflammatory bowel disease patients: a bone of contention.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2005 May; 2(5):199. PubMed ID: 16265185
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease.
    Vestergaard P
    Minerva Med; 2004 Dec; 95(6):469-80. PubMed ID: 15785432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoporosis at presentation of childhood ALL: management with pamidronate.
    Goldbloom EB; Cummings EA; Yhap M
    Pediatr Hematol Oncol; 2005; 22(7):543-50. PubMed ID: 16166046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health care for osteoporosis in inflammatory bowel disease: unmet needs in care of male patients?
    Walldorf J; Krummenerl A; Engler K; Busch J; Dollinger MM; Seufferlein T; Albert JG
    J Crohns Colitis; 2013 Dec; 7(11):901-7. PubMed ID: 23333038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A decision tree-based approach for determining low bone mineral density in inflammatory bowel disease using WEKA software.
    Firouzi F; Rashidi M; Hashemi S; Kangavari M; Bahari A; Daryani NE; Emam MM; Naderi N; Shalmani HM; Farnood A; Zali M
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1075-81. PubMed ID: 17998832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bone Metabolism in Inflammatory Bowel Diseases 2].
    Kupka T; Svoboda P; Bojková M; Blaho M; Vašura A; Hrabovský V; Dítě P
    Vnitr Lek; 2020; 66(7):432-436. PubMed ID: 33380122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bone metabolism in inflammatory bowel diseases 1].
    Kupka T; Svoboda P; Bojková M; Blaho M; Vašura A; Hrabovský V; Dítě P
    Vnitr Lek; 2020; 66(7):3-7. PubMed ID: 33380127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
    Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P
    Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A strategy for osteoporosis in gastroenterology.
    Scott EM; Scott BB
    Eur J Gastroenterol Hepatol; 1998 Aug; 10(8):689-96; discussion 696-8. PubMed ID: 9744699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease.
    Bernstein CN; Bector S; Leslie WD
    Am J Gastroenterol; 2003 Nov; 98(11):2468-73. PubMed ID: 14638350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A double-blind placebo-controlled study of the effects of the bisphosphonate risedronate on bone mass in patients with inflammatory bowel disease.
    Henderson S; Hoffman N; Prince R
    Am J Gastroenterol; 2006 Jan; 101(1):119-23. PubMed ID: 16405543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease.
    Shane E; Silverberg SJ; Donovan D; Papadopoulos A; Staron RB; Addesso V; Jorgesen B; McGregor C; Schulman L
    Am J Med; 1996 Sep; 101(3):262-9. PubMed ID: 8873487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.